ASX - By Stock
|
4DS |
Re:
Ann: Trading Halt
|
|
Billypepper
|
369 |
130K |
0 |
22/08/23 |
22/08/23 |
ASX - By Stock
|
369
|
130K
|
0
|
|
ASX - By Stock
|
BET |
Re:
Undervalued Cash flow positive business
|
|
Billypepper
|
398 |
140K |
1 |
28/07/23 |
28/07/23 |
ASX - By Stock
|
398
|
140K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Results of Scheme Meeting
|
|
Billypepper
|
250 |
80K |
1 |
07/09/22 |
07/09/22 |
ASX - By Stock
|
250
|
80K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Best and Final Confirmation and Bridging Loan
|
|
Billypepper
|
242 |
65K |
2 |
16/08/22 |
16/08/22 |
ASX - By Stock
|
242
|
65K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Vote NO Pfizer offer
|
|
Billypepper
|
555 |
188K |
16 |
20/04/22 |
20/04/22 |
ASX - By Stock
|
555
|
188K
|
16
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Proposed Acquisition of ResApp Health by Pfizer
|
|
Billypepper
|
687 |
254K |
5 |
11/04/22 |
11/04/22 |
ASX - By Stock
|
687
|
254K
|
5
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp announces positive results of COVID-19 screening test
|
|
Billypepper
|
530 |
150K |
9 |
22/03/22 |
22/03/22 |
ASX - By Stock
|
530
|
150K
|
9
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Section 708A Notice and Appendix 2A
|
|
Billypepper
|
132 |
30K |
6 |
02/07/20 |
02/07/20 |
ASX - By Stock
|
132
|
30K
|
6
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Pause In trading
|
|
Billypepper
|
118 |
46K |
1 |
01/10/19 |
01/10/19 |
ASX - By Stock
|
118
|
46K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension
|
|
Billypepper
|
490 |
244K |
59 |
27/10/18 |
27/10/18 |
ASX - By Stock
|
490
|
244K
|
59
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Voluntary Suspension
|
|
Billypepper
|
490 |
244K |
3 |
27/10/18 |
27/10/18 |
ASX - By Stock
|
490
|
244K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
Billypepper
|
224 |
112K |
1 |
24/10/18 |
24/10/18 |
ASX - By Stock
|
224
|
112K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
Billypepper
|
201 |
114K |
1 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
201
|
114K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Trading Halt
|
|
Billypepper
|
201 |
114K |
0 |
03/09/18 |
03/09/18 |
ASX - By Stock
|
201
|
114K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Update on Field Evaluation by Medecins Sans Frontieres
|
|
Billypepper
|
41 |
19K |
3 |
14/09/17 |
14/09/17 |
ASX - By Stock
|
41
|
19K
|
3
|
|
ASX - By Stock
|
RAP |
Re:
In trading halt
|
|
Billypepper
|
4 |
2.5K |
4 |
31/07/17 |
31/07/17 |
ASX - By Stock
|
4
|
2.5K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
In trading halt
|
|
Billypepper
|
4 |
2.5K |
0 |
31/07/17 |
31/07/17 |
ASX - By Stock
|
4
|
2.5K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
Top-line US results
|
|
Billypepper
|
159 |
69K |
4 |
21/07/17 |
21/07/17 |
ASX - By Stock
|
159
|
69K
|
4
|
|
ASX - By Stock
|
RAP |
Re:
Top-line US results
|
|
Billypepper
|
159 |
69K |
0 |
21/07/17 |
21/07/17 |
ASX - By Stock
|
159
|
69K
|
0
|
|
ASX - By Stock
|
RAP |
Re:
survey
|
|
Billypepper
|
24 |
12K |
2 |
09/06/17 |
09/06/17 |
ASX - By Stock
|
24
|
12K
|
2
|
|
ASX - By Stock
|
RAP |
Re:
Ann: ResApp Provides SMARTCOUGH-C Study Update
|
|
Billypepper
|
110 |
44K |
1 |
15/03/17 |
15/03/17 |
ASX - By Stock
|
110
|
44K
|
1
|
|
ASX - By Stock
|
RAP |
Re:
Ann: Appendix 3B
|
|
Billypepper
|
20 |
12K |
0 |
14/02/17 |
14/02/17 |
ASX - By Stock
|
20
|
12K
|
0
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
Billypepper
|
8.4K |
3.1M |
2 |
14/02/17 |
14/02/17 |
Charts
|
8.4K
|
3.1M
|
2
|
|
Charts
|
RAP |
Re:
RAP charting
|
|
Billypepper
|
8.4K |
3.1M |
20 |
13/02/17 |
13/02/17 |
Charts
|
8.4K
|
3.1M
|
20
|
|